Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, by prescription, ...
PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback